CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mila B Ortigoza, MD, PhD
NYU Langone Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Yale University School of Medicine
New Haven, Connecticut, United States
- University of Miami Hospital and Clinics
Miami, Florida, United States
- Nyu Langone Health
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- University of Texas Rio Grande Valley
Edinburg, Texas, United States
- the University of Texas Health Science Center
Houston, Texas, United States
- the University of Texas Health Science Center
Tyler, Texas, United States
- Aurora St. Luke'S Medical Center
Milwaukee, Wisconsin, United States
- Medical College of Wisconsin / Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Apr 2020
- Primary completion
- 29 Mar 2021
- Completion
- 12 Dec 2022
- Last update posted
- 26 Jan 2023
- Registered enrollment
- 941
- Registry id
- NCT04364737
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.